Oral candidosis. Report of a case implicating Candida parapsilosis as a pathogen.
This article deals with the etiology, pathogenesis, clinical manifestations, diagnosis, and treatment of oral candidosis. Emphasis is placed on drug therapy, and the literature reviewed indicates that although many drugs are available, amphotericin B (10 mg. lozenges) is favored as the drug of choice in the treatment of this condition. Attention is drawn to predisposing factors, particularly diabetes mellitus. A case in which the pathogen was identified as Candida parapsilosis is reported.
D000666:Amphotericin B / Q000627:therapeutic use; D002175:Candida / Q000145:classification; D002180:Candidiasis, Oral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000382:microbiology* / Q000473:pathology / Q000628:therapy; D003677:Deficiency Diseases / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use
D009761:Nystatin; D000666:Amphotericin B